Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: A randomized controlled trial

Jonathan Shuter, Daniela A. Morales, Shannon E. Considine-Dunn, Lawrence C. An, Cassandra A. Stanton

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Objective: To evaluate the feasibility and preliminary efficacy of a Web-based tobacco treatment for persons living with HIV (PLWH). Design: Prospective, randomized controlled trial. Setting: HIV-care center in the Bronx, New York. Subjects: Eligibility criteria included HIV infection, current tobacco usage, interest in quitting, and access to a computer with internet. One hundred thirty-eight subjects enrolled, and 134 completed the study. Intervention: Positively Smoke Free on the Web (PSFW), an 8-session, 7-week targeted tobacco treatment program for PLWH, was compared with standard care (brief advice to quit and self-help brochure). All subjects were offered nicotine patches. Main Outcome Measures: The main feasibility outcomes were number of sessions logged into, number of Web pages visited, number of interactive clicks, and total time logged in. The main efficacy outcome was biochemically verified, 7-day point prevalence abstinence 3 months after intervention. Results: PSFW subjects logged into a mean of 5.5 of 8 sessions and 26.2 of 41 pages. They executed a mean of 10 interactive clicks during a mean total of 59.8 minutes logged in. Most required reminder phone calls to complete the sessions. Educational level, anxiety score, and home access of the Web site were associated with Web site usage. Ten percent of the PSFW group vs. 4.3% of controls achieved the abstinence end point. Among those who completed all 8 sessions, 17.9% were abstinent, and among women completers, 30.8% were abstinent. Conclusions: Web-based treatment is a feasible strategy for PLWH smokers, and preliminary findings suggest therapeutic efficacy.

Original languageEnglish (US)
Pages (from-to)59-66
Number of pages8
JournalJournal of Acquired Immune Deficiency Syndromes
Volume67
Issue number1
DOIs
StatePublished - Sep 1 2014

Fingerprint

Smoking Cessation
Randomized Controlled Trials
HIV
Smoke
Tobacco
Tobacco Use Cessation Products
Pamphlets
Therapeutics
Internet
HIV Infections
Anxiety
Outcome Assessment (Health Care)

Keywords

  • cigarette
  • HIV
  • internet
  • smoking
  • tobacco
  • treatment

ASJC Scopus subject areas

  • Infectious Diseases
  • Pharmacology (medical)
  • Medicine(all)

Cite this

Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers : A randomized controlled trial. / Shuter, Jonathan; Morales, Daniela A.; Considine-Dunn, Shannon E.; An, Lawrence C.; Stanton, Cassandra A.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 67, No. 1, 01.09.2014, p. 59-66.

Research output: Contribution to journalArticle

Shuter, Jonathan ; Morales, Daniela A. ; Considine-Dunn, Shannon E. ; An, Lawrence C. ; Stanton, Cassandra A. / Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers : A randomized controlled trial. In: Journal of Acquired Immune Deficiency Syndromes. 2014 ; Vol. 67, No. 1. pp. 59-66.
@article{7a24631c2079450eb2618885ecf567d7,
title = "Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: A randomized controlled trial",
abstract = "Objective: To evaluate the feasibility and preliminary efficacy of a Web-based tobacco treatment for persons living with HIV (PLWH). Design: Prospective, randomized controlled trial. Setting: HIV-care center in the Bronx, New York. Subjects: Eligibility criteria included HIV infection, current tobacco usage, interest in quitting, and access to a computer with internet. One hundred thirty-eight subjects enrolled, and 134 completed the study. Intervention: Positively Smoke Free on the Web (PSFW), an 8-session, 7-week targeted tobacco treatment program for PLWH, was compared with standard care (brief advice to quit and self-help brochure). All subjects were offered nicotine patches. Main Outcome Measures: The main feasibility outcomes were number of sessions logged into, number of Web pages visited, number of interactive clicks, and total time logged in. The main efficacy outcome was biochemically verified, 7-day point prevalence abstinence 3 months after intervention. Results: PSFW subjects logged into a mean of 5.5 of 8 sessions and 26.2 of 41 pages. They executed a mean of 10 interactive clicks during a mean total of 59.8 minutes logged in. Most required reminder phone calls to complete the sessions. Educational level, anxiety score, and home access of the Web site were associated with Web site usage. Ten percent of the PSFW group vs. 4.3{\%} of controls achieved the abstinence end point. Among those who completed all 8 sessions, 17.9{\%} were abstinent, and among women completers, 30.8{\%} were abstinent. Conclusions: Web-based treatment is a feasible strategy for PLWH smokers, and preliminary findings suggest therapeutic efficacy.",
keywords = "cigarette, HIV, internet, smoking, tobacco, treatment",
author = "Jonathan Shuter and Morales, {Daniela A.} and Considine-Dunn, {Shannon E.} and An, {Lawrence C.} and Stanton, {Cassandra A.}",
year = "2014",
month = "9",
day = "1",
doi = "10.1097/QAI.0000000000000226",
language = "English (US)",
volume = "67",
pages = "59--66",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers

T2 - A randomized controlled trial

AU - Shuter, Jonathan

AU - Morales, Daniela A.

AU - Considine-Dunn, Shannon E.

AU - An, Lawrence C.

AU - Stanton, Cassandra A.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Objective: To evaluate the feasibility and preliminary efficacy of a Web-based tobacco treatment for persons living with HIV (PLWH). Design: Prospective, randomized controlled trial. Setting: HIV-care center in the Bronx, New York. Subjects: Eligibility criteria included HIV infection, current tobacco usage, interest in quitting, and access to a computer with internet. One hundred thirty-eight subjects enrolled, and 134 completed the study. Intervention: Positively Smoke Free on the Web (PSFW), an 8-session, 7-week targeted tobacco treatment program for PLWH, was compared with standard care (brief advice to quit and self-help brochure). All subjects were offered nicotine patches. Main Outcome Measures: The main feasibility outcomes were number of sessions logged into, number of Web pages visited, number of interactive clicks, and total time logged in. The main efficacy outcome was biochemically verified, 7-day point prevalence abstinence 3 months after intervention. Results: PSFW subjects logged into a mean of 5.5 of 8 sessions and 26.2 of 41 pages. They executed a mean of 10 interactive clicks during a mean total of 59.8 minutes logged in. Most required reminder phone calls to complete the sessions. Educational level, anxiety score, and home access of the Web site were associated with Web site usage. Ten percent of the PSFW group vs. 4.3% of controls achieved the abstinence end point. Among those who completed all 8 sessions, 17.9% were abstinent, and among women completers, 30.8% were abstinent. Conclusions: Web-based treatment is a feasible strategy for PLWH smokers, and preliminary findings suggest therapeutic efficacy.

AB - Objective: To evaluate the feasibility and preliminary efficacy of a Web-based tobacco treatment for persons living with HIV (PLWH). Design: Prospective, randomized controlled trial. Setting: HIV-care center in the Bronx, New York. Subjects: Eligibility criteria included HIV infection, current tobacco usage, interest in quitting, and access to a computer with internet. One hundred thirty-eight subjects enrolled, and 134 completed the study. Intervention: Positively Smoke Free on the Web (PSFW), an 8-session, 7-week targeted tobacco treatment program for PLWH, was compared with standard care (brief advice to quit and self-help brochure). All subjects were offered nicotine patches. Main Outcome Measures: The main feasibility outcomes were number of sessions logged into, number of Web pages visited, number of interactive clicks, and total time logged in. The main efficacy outcome was biochemically verified, 7-day point prevalence abstinence 3 months after intervention. Results: PSFW subjects logged into a mean of 5.5 of 8 sessions and 26.2 of 41 pages. They executed a mean of 10 interactive clicks during a mean total of 59.8 minutes logged in. Most required reminder phone calls to complete the sessions. Educational level, anxiety score, and home access of the Web site were associated with Web site usage. Ten percent of the PSFW group vs. 4.3% of controls achieved the abstinence end point. Among those who completed all 8 sessions, 17.9% were abstinent, and among women completers, 30.8% were abstinent. Conclusions: Web-based treatment is a feasible strategy for PLWH smokers, and preliminary findings suggest therapeutic efficacy.

KW - cigarette

KW - HIV

KW - internet

KW - smoking

KW - tobacco

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=84906063993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906063993&partnerID=8YFLogxK

U2 - 10.1097/QAI.0000000000000226

DO - 10.1097/QAI.0000000000000226

M3 - Article

C2 - 25118794

AN - SCOPUS:84906063993

VL - 67

SP - 59

EP - 66

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 1

ER -